Literature DB >> 10460872

Eosinophilic alveolitis in BAL after lung transplantation.

B Bewig1, S Stewart, H Böttcher, A Bastian, A Tiroke, S Hirt, A Haverich.   

Abstract

Lung transplantation has become a therapeutic option for patients with end stage lung disease. However, outcome after transplantation is complicated by episodes of rejection and infections. Bronchoalveolar lavage is a valuable tool in monitoring patients after transplantation, since it allows the detection of pathogens. A marker specifically indicating rejection from changes in BAL fluid has not been found yet. Especially changes in differential cell count, like lymphocytosis or an increase in polymorphnuclear granulocytes, are unspecific. The role of high eosinophil levels in BAL has not been elucidated yet. We analyzed 25 BAL samples and clinical data of 4 patients who underwent lung transplantation and presented with recurrent episodes of eosinophilic alveolitis in BAL. All patients demonstrated a deterioration of clinical condition, lung function, and blood gas analysis during times of eosinophilia in BAL, compared to previous examinations. In all cases, eosinophilia in BAL was accompanied by rejection. All patients were finally treated with high doses of steroids, resulting in improvement of all parameters. Eosinophilia was not associated with significant changes in the IL-5 concentration in BAL or the pattern of IL-5 expression in BAL cells. In conclusion, eosinophilic alveolitis may indicate acute rejection in patients after lung transplantation, if other causes of eosinophilia are excluded.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10460872      PMCID: PMC7096104          DOI: 10.1007/s001470050221

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  6 in total

1.  Cxcr3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection.

Authors:  C Agostini; F Calabrese; F Rea; M Facco; A Tosoni; M Loy; G Binotto; M Valente; L Trentin; G Semenzato
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

2.  Peripheral blood and bronchoalveolar leukocyte profile in lung transplant recipients and their changes according to immunosuppressive regimen: A single-center experience.

Authors:  Zsuzsanna Jáky-Kováts; Melinda Vámos; Zsolt István Komlósi; András Bikov; Ildikó Madurka; Gergő Szűcs; Veronika Müller; Anikó Bohács
Journal:  Immun Inflamm Dis       Date:  2022-08

Review 3.  Solving the Conundrum of Eosinophils in Alloimmunity.

Authors:  Cherie Alissa Lynch; Yizhan Guo; Zhongcheng Mei; Daniel Kreisel; Andrew E Gelman; Elizabeth A Jacobsen; Alexander Sasha Krupnick
Journal:  Transplantation       Date:  2021-12-27       Impact factor: 5.385

4.  Bronchoalveolar lavage cell immunophenotyping facilitates diagnosis of lung allograft rejection.

Authors:  J R Greenland; N P Jewell; M Gottschall; N N Trivedi; J Kukreja; S R Hays; J P Singer; J A Golden; G H Caughey
Journal:  Am J Transplant       Date:  2014-02-11       Impact factor: 8.086

5.  Mechanistic differences between phenotypes of chronic lung allograft dysfunction after lung transplantation.

Authors:  Monika I Suwara; Bart M Vanaudenaerde; Stijn E Verleden; Robin Vos; Nicola J Green; Chris Ward; Lee A Borthwick; Elly Vandermeulen; Jim Lordan; Dirk E Van Raemdonck; Paul A Corris; Geert M Verleden; Andrew J Fisher
Journal:  Transpl Int       Date:  2014-06-17       Impact factor: 3.782

Review 6.  Diagnostic value of plasma and bronchoalveolar lavage samples in acute lung allograft rejection: differential cytology.

Authors:  Nicole E Speck; Macé M Schuurmans; Christian Murer; Christian Benden; Lars C Huber
Journal:  Respir Res       Date:  2016-06-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.